Home
>
National Drug Code (NDC)
>
Ibandronate Sodium
Ibandronate Sodium - 0378-5215-53 - (ibandronate sodium)
Drug Information of Ibandronate Sodium
| Product NDC: | 0378-5215 |
| Proprietary Name: | Ibandronate Sodium |
| Non Proprietary Name: | ibandronate sodium |
| Active Ingredient(s): | 150 mg/1 & nbsp; ibandronate sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ibandronate Sodium
| Product NDC: | 0378-5215 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078995 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120319 |
Package Information of Ibandronate Sodium
| Package NDC: | 0378-5215-53 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (0378-5215-53) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of Ibandronate Sodium
| NDC Code | 0378-5215-53 |
| Proprietary Name | Ibandronate Sodium |
| Package Description | 3 BLISTER PACK in 1 CARTON (0378-5215-53) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 0378-5215 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ibandronate sodium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120319 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
